Population-based analysis of survival after childhood cancer diagnosed during 1970-1998: A report from the Childhood Cancer Registry of Piedmont, Italy

Haematologica

Volumn 88, Issue 9, 2003, Pages 974-982

  Viscomi, Silvia ^a   Pastore, Guido ^a,b   Mosso, Maria Luisa ^a   Terracini, Benedetto ^a   Madon, Enrico ^e   Magnani, Corrado ^a,c,d   Merletti, Franco ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b SANT'ANDREA HOSPITAL   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d Childhood Cancer Registry of Piedmont   (Italy)

^e NONE

Author keywords

Childhood cancer; Population based studies; Prognosis cancer registries; Survival

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER REGISTRY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; DEVELOPED COUNTRY; HUMAN; INFANT; ITALY; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; POPULATION RESEARCH; PROGNOSIS; SURVIVAL RATE; FEMALE; HEALTH SURVEY; MALE; METHODOLOGY; MORTALITY; NEOPLASM; NEWBORN; PRESCHOOL CHILD; REGISTER; STATISTICS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; ITALY; MALE; NEOPLASMS; POPULATION SURVEILLANCE; REGISTRIES; SURVIVAL RATE;

EID: 0141702169     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Chan KW. Acute lymphoblastic leukaemia. Review. Curr Probl Pediatr Adolesc Health Care 2002;32:40-9.
2. Reddy AT. Advances in biology and treatment of childhood brain tumours. Review. Curr Neurol Neurosci Rep 2001;1:137-43.
3. Thornton AF Jr, Sandler HM, Ten Haken RK, McShan DL, Fraass BA, La Vigne ML, et al. The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasm. Int J Radiat Oncol Biol Phys 1992;24:767-75.
4. th ed. Philadelphia: Lippincott, Williams and Wilkins, 2002. p. 489-544.
5. Terracini B, Coebergh J, Gatta G, Magnani C, Stiller C, Verdecchia A, et al. Childhood cancer survival in Europe, an overview. Eur J Cancer 2001;37:810-81.
6. th ed. Philadelphia: Lippincott, Williams and Wilkins, 2002. p. 1-1687.
7. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK, eds. SEER Cancer Statistics Review, 1973-1999, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1973_1999/2002.
8. Mosso ML, Colombo R, Giordano L, Pastore G, Terracini B, Magnani C. Childhood cancer registry of the Province of Torino, Italy. Survival, incidence and mortality. Cancer 1992;69:1300-5.
9. Pastore G, Mosso ML, Carnevale F, Cordero di Montezemolo L, Forni M, Madon E, et al. Survival trends of childhood cancer diagnosed during 1970-1994 in Piedmont, Italy: a report from the Childhood Cancer Registry. Med Pediatr Oncol 2001;36:481-8.
10. World Health Organisation. International classification of disease for oncology Version 1. WHO. Geneva, 1976.
11. Birch JM, Marsden HB. A classification scheme for childhood cancer. Int J Cancer 1987;40:620-4.
12. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
13. th ed. New York: John Wiley Et Sons, 1993. p. 801-3.
14. Peto, R, Pike, MC, Armitage, P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II, analysis and examples. Br J Cancer 1977;35:1-39.
15. Cox DR. Regression models and life tables. J R Soc Stat 1972;34:187-220.
16. Stiller CA. Population based survival rates for childhood cancer in Britain 1980-91. Br Med J 1994;309:1612-6.
17. Coebergh JW, Pastore G, Gatta G, Corazziari I, Kamps W and the Eurocare Working Group. Variation in survival of European children with acute lymphoblastic leukaemia, diagnosed in 1978-92: the EUROCARE study. Eur J Cancer 2001;37:687-94.
18. Gatta G, Luksch R, Cleman MP, Corazziari I. Survival from acute non-lymphocitic leukaemia (ANLL) and chronic myeloid leukaemia (CML) in European children since 1978: a population based study. The EUROCARE Working Group. Eur J Cancer 2001;37:695-702.
19. Pastore G, Magnani C, Verdecchia A, Pession A, Viscomi S, Coebergh JW and the EUROCARE Working Group. Survival of childhood lymphomas in Europe, 1978-1992: a report from the EUROCARE study. Eur J Cancer 2001;37:703-10.
20. Magnani C, Aareleid T, Viscomi S, Pastore G, Berrino F. Variation in survival of children with central nervous system (CNS) malignancies diagnosed in Europe between 1978 and 1992: the EUROCARE study. The Eurocare Working Group. Eur J Cancer 2001;37:711-21.
21. Spix C, Aareleid T, Stiller C, Magnani C, Kaatsch P, Michaelis J and the Eurocare Working Group. Survival of children neuroblastoma: time trends and regional differences in Europe, 1978-1992. Eur J Cancer 2001;37:722-9.
22. Sant M, Capocaccia R, Badioni V. Survival for retinoblastoma in Europe. The Eurocare Working Group. Eur J Cancer 2001;37:730-5.
23. Plesko I, Kramarova E, Stiller CA, Coebergh JW, Santaquilani M and the Eurocare Working Group. Survival of children with Wilm's tumour in Europe. Eur J Cancer 2001;37:736-43.
24. Stiller CA, Craft AW, Corazziari I. Survival of children with bone sarcoma in Europe since 1978: results from the EUROCARE study. The Eurocare Working Group. Eur J Cancer 2001;37:760-6.
25. Magnani C, Pastore G and the Itacare Working Group. Survival of childhood cancer patients in Italy, 1978-89. Tumori 1997;83:426-89.
26. Magnani C, Pannelli F, Mosciatti P, Viscomi S, Rosso S, Spitale AB, et al. Analisi della sopravvivenza per tumore infantile: dati dai registri tumori italiani. Epidemiologia Et Prevenzione 2001;25 Suppl 1:347-75.
27. Haupt R, Valsecchi MG, Silvestri D, Masera G, Terracini B, Jankovic M. Early and late deaths after elective end of therapies for childhood cancer in Italy. Int J Cancer 2000;86:393-8.
28. Moller TR, Garwicz S, Borlow L, Falck Winter J, Glottre E. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the nordic Countries. J Clin Oncol 2001;19:3173-81.
29. Mertens A, Yasui Y, Neglia JP, Potter JD, Nesbit ME Jr, Ruccione K, et al. Late mortality experience in the five-years survivors of childhood and adolescence cancer: The childhood cancer survivors study. J Clin Oncol 2001;19:3163-72.
30. Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukaemia. J Clin Oncol 1996;14:18-24.
31. Greaves M. Childhood leukaemia Review. Br Med J 2002;324:283-7.
32. Stiller CA, Eatock EM. Patterns of care and survival for children with acute lymphoblastic leukaemia diagnosed between 1980 and 1994. Arch Dis Child 1999;81:202-8.
33. Pui CH, Gaynon PS, Boyett JM, Chessells JM, Baruchel A, Kamps W, et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 2002;359:1909-15.
34. Schillinger JA, Grosclaude PC, Honjo S, Quinn MJ, Sloggett A, Coleman MP. Survival after acute lymphocytic leukaemia: effects of socioeconomic status and geographic region. Arch Dis Child 1999;80:311-7.
35. Stiller CA, Eatock EM. Survival from acute non-lmphocytic Leukaemia, 1971-88: a population based study. Arch Dis Child 1994;70:219-23.
36. th ed. Philadelphia: Lippincot, Williams and Wilkins. 2002:895-938.
37. Goodman MT, Gurney JG, Smith MA, Olshan AF. Sympathetic nervous system tumours. In: Ries LAG, Smith MA, Gurney JG, eds. Cancer incidence and survival among children and adolescents: United States SEER program 1975-1995 NIH Publication No. 99-4649, Bethesda, MD, 1999. p. 65-72.
38. Sauvat F, Sarnacki S, Brisse H, Medioni J, Rubie H, Aigrain Y, et al. Outcome of suprarenal localised masses diagnosed during perinatal period: a retrospective multicenter study. Cancer 2002;94:2474-80.
39. Powell JE, Esteve J, Mann JR, Parker L, Frappaz D, Michaelis J, et al. Neuroblastoma in Europe: differences in the pattern of disease in the UK. SENSE. Study group for the evaluation of Neuroblastoma screening in Europe. Lancet 1998;352:682-7.
40. Woods WG, Gao RN, Shuster JJ, Robison LL, Bernstein M, Weitzman S, et al. Screening of infants and mortality due to neuroblastoma. N Engl J Med 2002;346:1041-6.
41. Schilling FH, Spix C, Berthold F, Erttmann R, Fehse N, Hero B et al. Neuroblastoma screening at one year of age. N Engl J Med 2002;346:1047-53.
42. Gatta G, Capocaccia R, Coleman M, Ries LA, Berrino F. Childhood cancer survival in Europe and the United States. Cancer 2002;95:1767-72.
43. Stiller CA. Centralisation of treatment and survival rates for cancer. Arch Dis Child 1988;63:23-30.
44. Kramer S, Meadows AT, Pastore G, Jarrett BD. Influence of place of treatment on diagnosis, treatment and survival in three paediatric solid tumors. J Clin Oncol 1984;2:917-23.
45. Foreman N, Thorne RN, Mott MG. Variation in survival of children with cancer within a region of United Kingdom. Cancer 1996;77:785-90.
46. Pession A, Rondelli R, Haupt R, Magnani C, Pastore G, Terracini B, et al. II sistema di rilevazione dei casi di tumore maligno in eta' pediatrica in Italia. Riv Ital Pediatr 2000;26:333-41.